Publicacións nas que colabora con Francisco de Borja García-Cosío Piqueras (11)

2024

  1. Impact of comorbidities on the achievement of specific therapeutic goals in biologic-treated asthma patients

    Allergy: European Journal of Allergy and Clinical Immunology

2023

  1. Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 7, pp. 1934-1948

  2. Factors associated with suboptimal response to monoclonal antibodies in severe asthma

    Allergy: European Journal of Allergy and Clinical Immunology

  3. Redefining the Role of Bronchoscopy in the Workup of Severe Uncontrolled Asthma in the Era of Biologics: A Prospective Study

    Chest, Vol. 164, Núm. 4, pp. 837-845

2021

  1. Characterization of COPD admissions during the first COVID-19 outbreak

    International Journal of COPD, Vol. 16, pp. 1549-1554

2020

  1. Characteristics and treatment regimens across ERS SHARP severe asthma registries

    European Respiratory Journal, Vol. 55, Núm. 1

  2. Mepolizumab and reslizumab, two different options for severe asthma patients with prior failure to omalizumab

    Allergy: European Journal of Allergy and Clinical Immunology

2019

  1. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

    The Lancet Respiratory Medicine, Vol. 7, Núm. 1, pp. 46-59

  2. Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study

    Respiratory Medicine, Vol. 151, pp. 49-54

2018

  1. Asthma–COPD overlap: identification and optimal treatment

    Therapeutic Advances in Respiratory Disease, Vol. 12

2015

  1. Cumplimiento terapéutico y enfermedad pulmonar obstructiva crónica. Prevalencia, características y consecuencias

    Adhesión terapéutica en las enfermedades respiratorias (Viguera Editores), pp. 45-58